Bayer AG raised its annual profit outlook, buoyed by a better-than-expected performance at its pharmaceutical unit.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.
